1. In patients with obesity or dyslipidemia, corticosteroids may exacerbate weight gain and lipid abnormalities. Monitoring and adjusting lipid-lowering therapy is crucial.

2. Corticosteroids can raise blood glucose and worsen lipid profiles, making metabolic disorders like obesity and dyslipidemia more challenging. Close monitoring and lifestyle modifications may be necessary.

3. Use of corticosteroids in those with metabolic disorders requires care to avoid aggravating obesity or dyslipidemia. Regular monitoring of lipid and glucose levels is advised.

4. When prescribing corticosteroids for patients with obesity or dyslipidemia, consider potential effects on metabolic control. Strategies like diet adjustment and increased physical activity might be needed.